THE RANDY SHAVER CANCER RESEARCH AND COMMUNITY …

We know that bladder cancer responds to immunotherapy (based on the success of BCG). We also know that the BCG vaccine is not optimized for targeting bladder cancer cells (as it is a tuberculosis vaccine and functions by indirectly priming the immune system). ................
................